NO993341L - Analoger av paratyroidhormon - Google Patents

Analoger av paratyroidhormon

Info

Publication number
NO993341L
NO993341L NO993341A NO993341A NO993341L NO 993341 L NO993341 L NO 993341L NO 993341 A NO993341 A NO 993341A NO 993341 A NO993341 A NO 993341A NO 993341 L NO993341 L NO 993341L
Authority
NO
Norway
Prior art keywords
parathyroid hormone
analogues
pthrp
pth
acc
Prior art date
Application number
NO993341A
Other languages
English (en)
Norwegian (no)
Other versions
NO993341D0 (no
Inventor
Zheng Xin Dong
Original Assignee
Biomeasure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/779,768 external-priority patent/US5969095A/en
Application filed by Biomeasure Inc filed Critical Biomeasure Inc
Publication of NO993341D0 publication Critical patent/NO993341D0/no
Publication of NO993341L publication Critical patent/NO993341L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO993341A 1997-01-07 1999-07-06 Analoger av paratyroidhormon NO993341L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/779,768 US5969095A (en) 1995-07-13 1997-01-07 Analogs of parathyroid hormone
US08/813,534 US5955574A (en) 1995-07-13 1997-03-07 Analogs of parathyroid hormone
PCT/US1997/022498 WO1998030590A2 (en) 1997-01-07 1997-12-08 Analogs of parathyroid hormone

Publications (2)

Publication Number Publication Date
NO993341D0 NO993341D0 (no) 1999-07-06
NO993341L true NO993341L (no) 1999-09-06

Family

ID=27119618

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993341A NO993341L (no) 1997-01-07 1999-07-06 Analoger av paratyroidhormon

Country Status (23)

Country Link
US (1) US5955574A (pl)
EP (3) EP2206725A1 (pl)
JP (1) JP3963482B2 (pl)
KR (2) KR100497709B1 (pl)
CN (1) CN1137898C (pl)
AR (3) AR011517A1 (pl)
AT (2) ATE321784T1 (pl)
AU (1) AU741584B2 (pl)
BR (1) BR9714200A (pl)
CA (1) CA2276614C (pl)
CZ (2) CZ298937B6 (pl)
DE (2) DE69739912D1 (pl)
DK (2) DK0948541T3 (pl)
ES (2) ES2258286T3 (pl)
HU (1) HUP9904596A3 (pl)
IL (1) IL130794A0 (pl)
NO (1) NO993341L (pl)
NZ (1) NZ336610A (pl)
PL (1) PL191898B1 (pl)
PT (2) PT1645566E (pl)
RU (1) RU2198182C2 (pl)
SI (2) SI1645566T1 (pl)
WO (1) WO1998030590A2 (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544949B1 (en) * 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
US7410948B2 (en) * 1995-07-13 2008-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Analogs of parathyroid hormone
HRP20000109A2 (en) * 1997-09-09 2001-02-28 Hoffmann La Roche FRACTURE HEALING USING PTHrP ANALOGS
US7531621B1 (en) * 1998-05-05 2009-05-12 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. PTH2 receptor selective compounds
PL345583A1 (en) * 1998-07-20 2001-12-17 Sod Conseils Rech Applic Peptide analogues of pacap
US6660843B1 (en) † 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US6489297B1 (en) 2000-02-18 2002-12-03 Dabur Research Foundation Vasoactive intestinal peptide analogs
US20050124537A1 (en) * 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US6756480B2 (en) * 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
JP5073153B2 (ja) * 2001-06-01 2012-11-14 ノバルティス アーゲー 副甲状腺ホルモンおよびカルシトニンの経口投与
AU2002339843B2 (en) 2001-07-23 2007-12-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
AU2004264899A1 (en) * 2003-08-06 2005-02-24 Innophos, Inc. Method for promoting bone growth
CA2628945A1 (en) 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
BRPI0719821B8 (pt) * 2006-10-03 2021-05-25 Ipsen Pharma Sas composição estável na armazenagem apropriada para administração a pacientes
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
US7803770B2 (en) * 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
BRPI0719885B8 (pt) * 2006-10-13 2021-05-25 Lilly Co Eli peptídeos peguilados como moduladores de receptores de pth, seus usos, e composição.
CN104072606B (zh) 2007-08-01 2017-09-22 总医院有限公司 利用g蛋白偶联受体和相关组合物的筛选方法
WO2010111617A2 (en) 2009-03-27 2010-09-30 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
BR112012013725A2 (pt) 2009-12-07 2017-01-10 Univ Michigan Tech paratormônio de urso preto e métodos de usar o paratormônio de uso preto.
HUE030072T2 (en) 2010-05-12 2017-04-28 Radius Health Inc Therapeutic prescriptions
MX358161B (es) 2010-05-13 2018-08-06 The General Hospital Corp Star Analogos de hormona paratiroidea y usos para los mismos.
US9133182B2 (en) 2010-09-28 2015-09-15 Radius Health, Inc. Selective androgen receptor modulators
ES3055185T3 (en) 2014-03-28 2026-02-10 Univ Duke Treatment of an estrogen receptor positive breast cancer using a selective estrogen receptor modulator
KR20250152679A (ko) 2015-04-29 2025-10-23 래디어스 파마슈티컬스, 인코포레이티드 암을 치료하는 방법
CN108025042A (zh) * 2015-07-06 2018-05-11 董正欣 PTHrP类似物的新型制剂
MX389702B (es) 2016-06-22 2025-03-20 Ellipses Pharma Ltd Compuestos para usarse en el tratamiento de cancer de mama que expresa el receptor de androgenos (ar+).
JP7481115B2 (ja) 2017-01-05 2024-05-10 ラジウス ファーマシューティカルズ，インコーポレイテッド Ｒａｄ１９０１－２ｈｃｌの多形性形態
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
MX2020013713A (es) 2018-07-04 2021-03-02 Radius Pharmaceuticals Inc Formas polimorficas de rad1901-2hcl.
EP3924328A1 (en) 2019-02-12 2021-12-22 Radius Pharmaceuticals, Inc. Processes and compounds

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
EP0293158A3 (en) * 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroid hormone antagonists
JPH03504201A (ja) * 1989-02-23 1991-09-19 ゲゼルシャフト・フュア・ビオテクノロギッシェ・フォルシュンク・ミット・ベシュレンクテル・ハフツング　（ゲー・ベー・エフ） Ｐｔｈ変種をコードするｄｎａ配列、ｐｔｈ変種、発現ベクター、細菌宿主、利用と治療用組成物
CA2040264A1 (en) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
AU2807892A (en) * 1991-10-10 1993-05-03 Peter K.T. Pang Parathyroid hormone analogues and use in osteoporosis treatment
US5434246A (en) * 1992-03-19 1995-07-18 Takeda Chemical Industries, Ltd. Parathyroid hormone derivatives
CA2098639A1 (en) * 1992-06-19 1993-12-20 K. Anne Kronis Bone stimulating, non-vasoactive parathyroid hormone variants
US5821225A (en) * 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
DK0678018T3 (da) 1993-01-06 2003-04-28 Kinerton Ltd Ion molekylærkonjugater af bionedbrydelige polyestere og bioaktive polypeptider
WO1995002610A1 (en) * 1993-07-13 1995-01-26 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
JPH10511095A (ja) * 1994-12-19 1998-10-27 ベス イスラエル ディーコネス メディカル センター インコーポレイテッド 副甲状腺ホルモン又はその作動薬の低用量継続投与
CA2178894A1 (en) * 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone

Also Published As

Publication number Publication date
EP1645566A2 (en) 2006-04-12
SI0948541T1 (sl) 2006-06-30
CN1137898C (zh) 2004-02-11
AU5519998A (en) 1998-08-03
HUP9904596A3 (en) 2000-07-28
RU2198182C2 (ru) 2003-02-10
EP0948541B1 (en) 2006-03-29
EP1645566A3 (en) 2006-10-11
HUP9904596A1 (hu) 2000-06-28
KR100699422B1 (ko) 2007-03-28
EP0948541A2 (en) 1999-10-13
NO993341D0 (no) 1999-07-06
PL191898B1 (pl) 2006-07-31
DK0948541T3 (da) 2006-07-17
BR9714200A (pt) 2000-03-28
EP1645566B1 (en) 2010-06-16
CN1254347A (zh) 2000-05-24
IL130794A0 (en) 2001-01-28
AR011517A1 (es) 2000-08-30
CA2276614A1 (en) 1998-07-16
DE69735603D1 (de) 2006-05-18
ES2258286T3 (es) 2006-08-16
DE69739912D1 (de) 2010-07-29
WO1998030590A3 (en) 1998-12-10
HK1026215A1 (en) 2000-12-08
DE69735603T2 (de) 2006-11-30
ATE321784T1 (de) 2006-04-15
WO1998030590A9 (en) 1999-08-19
CZ298937B6 (cs) 2008-03-19
US5955574A (en) 1999-09-21
NZ336610A (en) 2001-07-27
AU741584B2 (en) 2001-12-06
PT948541E (pt) 2006-07-31
DK1645566T3 (da) 2010-09-27
JP2001508439A (ja) 2001-06-26
ES2347154T3 (es) 2010-10-26
KR100497709B1 (ko) 2005-06-23
CZ239899A3 (cs) 2000-01-12
KR20000069952A (ko) 2000-11-25
ATE471342T1 (de) 2010-07-15
CA2276614C (en) 2002-06-11
KR20060030006A (ko) 2006-04-07
PL334438A1 (en) 2000-02-28
EP2206725A1 (en) 2010-07-14
SI1645566T1 (sl) 2010-11-30
PT1645566E (pt) 2010-08-31
JP3963482B2 (ja) 2007-08-22
CZ301497B6 (cs) 2010-03-24
AR038552A2 (es) 2005-01-19
AR051906A2 (es) 2007-02-14
WO1998030590A2 (en) 1998-07-16

Similar Documents

Publication Publication Date Title
NO993341L (no) Analoger av paratyroidhormon
EA199901025A1 (ru) Пептидные аналоги паратиреоидного гормона
ATE285415T1 (de) Festphasige native chemische ligation von ungeschützten oder n-cystein-geschützten peptiden in wässrigen lösungen
BR9713294A (pt) "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano"
ATE304020T1 (de) Parathyroidhormon-verwandthe peptidanaloge
NZ527053A (en) Modified amyloid precursor protein polynucleotides and polypeptides
IL210454A (en) Antibody against a new ligand of cytokine 17zcytor
DE69638025D1 (de) Parathyroidhormon Analoge
EA200001071A1 (ru) Способ получения полимер-связанных циклических пептидов
ES8705919A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.
EP0293159A3 (en) Parathyroid hormone antagonists with simplified synthetic methodology
EP0293158A3 (en) Parathyroid hormone antagonists
HUP9701277A2 (hu) Eljárás parathiroid hormon és parathiroid hormonnal rokon peptidek analógjainak szintézisére
DK610888A (da) Cardiodilatinfragmentet, fremgangsmaade til fremstilling deraf samt dets anvendelse
EP0161007A3 (en) Retro - inverso c-terminal hexapeptide analogues of substance p
BR9815788B1 (pt) proteÍna quimÉrica.
DK0427863T3 (da) DNA, som koder for protein, som kan kombinere med forstærker for alfa-fetoprotein-gen
NO20012232L (no) Enzymatisk amidering av peptider
DE69434151D1 (de) Therapeutische inhaltsstoffe
TR200002611T2 (tr) Beta-lipotropin ve kullanımları
ATE207217T1 (de) Verfahren zur vermittlung von transaktionsschritten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application